六甲蜜胺
Altretamine;2,4,6-Tris(dimethylamino)-1,3,5-triazine;2,4,6-tris-1,3,5-triazine;ENT-50852;Hemel;Hexalen;Hexastat;Hexylen;HMM;HTM;N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-2,4,6-triamine;N,N,N’,N’,N″,N″-hexamethyl-1,3,5-triazine-2,4,6-triamine;N2,N2,N4,N4,N6,N6-hexamethyl-1,3,5-triazine-2,4,6-triamine;NC 195;RB-1515;WR-95704;HEXAMETHYLMELAMINE;Altretaminum;Altretamina;Melamine, hexamethyl-;Altretaminum [INN-Latin];ENT 50852;2,4,6-Tris(dimethylamino)-s-triazine;Altretamina [INN-Spanish];Altretamine (Hexalen);HXM;s-Triazine, 2,4,6-tris(dimethylamino)-;1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N'',N''-hexamethyl-;MLS;NCI-C50259;ALTRETAMINE [MART.];NINDS_000772;HMS1383L15;NCGC00015100-08;Q8BIH59O7H;DTXCID902579;645-05-6 (free base);Opera_ID_1095;HMS3372H17;UNII-Q8BIH59O7H;SR-01000000117-2;AB00052308;HMS502G14;HMS1570N14;SR-01000000117;MLS000069621;NCGC00015100-12;NCGC00015100-01;KBioGR_001388;NCGC00015100-06;Hexalen (TN);Altretamine, United States Pharmacopeia (USP) Reference Standard;N~2~,N~2~,N~4~,N~4~,N~6~,N~6~-Hexamethyl-1,3,5-triazine-2,4,6-triamine;Spectrum4_001064;ALTRETAMINE [HSDB];Altretamine (USP/INN);NCGC00021216-06;NS00006180;Prestwick2_000946;Lopac-A-8723;HMS3259I20;CHEMBL1455;2,4, 6-Tris(dimethylamino)-1,3,5-triazine;D02841;HMS1922C05;ChemDiv2_005185;NCGC00021216-05;s-Triazine,4,6-tris(dimethylamino)-;BSPBio_000912;CCRIS 5492;s1278;EU-0100083;SBI-0050071.P003;Altretamine [USAN:USP:INN:BAN];ALTRETAMINE [MI];HMS2090G17;DTXSID4022579;LP00083;Hexalen [Antineoplastic];MFCD00549245;BRN 0195058;HMS2097N14;SPBio_003071;SDCCGSBI-0050071.P004;1,5-Triazine-2,4,6-triamine, N,N,N',N',N'',N''-hexamethyl-;KBio3_002042;2,6-Tris(dimethylamino)-s-triazine;KBioSS_001788;Prestwick1_000946;BDBM37631;BRD-K67043667-001-15-7;DB00488;EINECS 211-428-4;IDI1_000772;NSC 13875;AI3-50852;NCGC00021216-04;KBio1_000772;Tox21_110085_1;J-523408;NCGC00015100-11;EN300-122382;SCHEMBL4206;N2,N2,N4,N4,N6,N6-Hexamethyl-1,3,5-trazne-2,4,6-tramne;ALTRETAMINE [WHO-DD];NCGC00021216-03;CHEBI:24564;2,6-Tris(dimethylamino)-1,3,5-triazine;WLN: T6N CN ENJ BN1&1 DN1&1 FN1&1;Cambridge id 5148727;NCGC00015100-15;ALTRETAMINE [USP MONOGRAPH];NCGC00015100-23;CAS-654-05-6;BCP27675;A834788;HSDB 7559;SR-01000000117-6;Q415242;C76020;CS-2061;AB00052308-17;Prestwick3_000946;CCG-2238;DivK1c_000772;MLS001076123;IDI1_003900;KBio2_006924;FT-0651499;Prestwick0_000946;NCGC00015100-09;Pharmakon1600-01503065;InChI=1/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H;NSC-13875;GTPL7112;ALTRETAMINE [VANDF];altretamine;KS-5247;1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N',N'-hexamethyl-;NCGC00015100-14;ALTRETAMINE [USP-RS];AB00052308_19;Z57931197;645-05-6;AB00052308_20;BPBio1_001004;ALTRETAMINE [ORANGE BOOK];Tox21_202784;Spectrum2_000907;A 8723;AB00052308-18;NCGC00015100-10;KB-913;2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine;BCPP000413;AKOS001729401;CAS-645-...